How to Advocate for Yourself With UC
When you have ulcerative colitis (UC), you have to be able to stand up for yourself when it comes to getting the proper medical care and making sure you’re taking care of yourself. Learn how -- from doctors who treat UC every day. (Source: WebMD Health)
Source: WebMD Health - January 22, 2021 Category: Consumer Health News Source Type: news

Device may predict inflammatory bowel flares using human sweat
A new wearable device may help people with inflammatory bowel disease, more quickly predict when flare-ups will occur, a study presented Thursday during the Crohn's& Colitis Congress found. (Source: Health News - UPI.com)
Source: Health News - UPI.com - January 21, 2021 Category: Consumer Health News Source Type: news

5-ASA-intolerance and Increased Risk of Colectomy for UC 5-ASA-intolerance and Increased Risk of Colectomy for UC
5-aminosalicylate is first-line therapy in ulcerative colitis, but some patients cannot tolerate its side effects. Are these patients at higher risk of colectomy?Alimentary Pharmacology & Therapeutics (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - January 20, 2021 Category: Surgery Tags: Gastroenterology Journal Article Source Type: news

5-ASA-intolerance and Increased Risk of Colectomy for UC 5-ASA-intolerance and Increased Risk of Colectomy for UC
5-aminosalicylate is first-line therapy in ulcerative colitis, but some patients cannot tolerate its side effects. Are these patients at higher risk of colectomy?Alimentary Pharmacology & Therapeutics (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 20, 2021 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Ultrasound predicts ulcerative colitis treatment response
Ultrasound scans may help physicians predict which patients with severe ulcerative...Read more on AuntMinnie.comRelated Reading: Ultrasound predicts which kids benefit from colitis meds Cinematic rendering complements CT in diagnosing colitis Immuno-PET could aid patients with inflammatory diseases 3 ways cinematic rendering can bolster colon evaluation PET/CT enhances detection of inflammatory bowel disease (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - January 11, 2021 Category: Radiology Source Type: news

Researchers engineer novel disease model to identify potential targets for ulcerative colitis drugs
(Cleveland Clinic) As reported in Nature Communications, researchers from Cleveland Clinic's Lerner Research Institute have developed a novel, patient-derived model of ulcerative colitis, which will help advance studies into new treatments for the chronic inflammatory bowel disease. The team used the model to identify a promising target that could be inhibited to slow disease progression. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 11, 2021 Category: International Medicine & Public Health Source Type: news

Polygenic Risk Scores May Improve IBD Risk Prediction
MONDAY, Jan. 4, 2021 -- Risk scores from multiethnic populations improve risk prediction for inflammatory bowel disease (IBD), according to a study published online Dec. 24 in Gastroenterology. Kyle Gettler, Ph.D., from the Icahn School of Medicine... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 4, 2021 Category: Pharmaceuticals Source Type: news

Inflammatory Bowel Disease (IBD)
Title: Inflammatory Bowel Disease (IBD)Category: Diseases and ConditionsCreated: 6/5/2000 12:00:00 AMLast Editorial Review: 12/31/2020 12:00:00 AM (Source: MedicineNet Digestion General)
Source: MedicineNet Digestion General - December 31, 2020 Category: Nutrition Source Type: news

Pandemic leaves chronically ill without critical access to washrooms
Mapping the nearest washrooms before leaving home is routine for Remo Testini. For 14 years, he’s been living with Crohn's disease — a chronic inflammatory bowel condition that can lead to severe abdominal pain and a sudden urgent need to use a restroom, among other issues. (Source: CBC | Health)
Source: CBC | Health - December 28, 2020 Category: Consumer Health News Tags: News/Canada/British Columbia Source Type: news

Her Stomach Hurt Unbearably. Her Doctors Were Baffled.
Then she remembered a story from her mother. (Source: NYT Health)
Source: NYT Health - December 28, 2020 Category: Consumer Health News Authors: Lisa Sanders, M.D. Tags: Crohn ' s Disease Digestive Tract Genetics and Heredity Medicine and Health Source Type: news

Study: Genetic data can help predict IBD risk
Genetic data from people of different racial and ethnic backgrounds can be used to predict a person's risk for inflammatory bowel disease, according to an analysis published in the journal Gastroenterology. (Source: Health News - UPI.com)
Source: Health News - UPI.com - December 24, 2020 Category: Consumer Health News Source Type: news

Multi-population risk scores could improve risk prediction for inflammatory bowel diseases, study finds
(The Mount Sinai Hospital / Mount Sinai School of Medicine) New study illustrates how studying diverse populations can help predict patient outcomes and reduce health disparities (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 24, 2020 Category: International Medicine & Public Health Source Type: news

UC: Can the Autoimmune Protocol Diet Help?
Can a diet called the autoimmune protocol, or AIP, improve your ulcerative colitis? Possibly. Some people say elimination diets, like AIP and others, put their disease in remission. (Source: WebMD Health)
Source: WebMD Health - December 21, 2020 Category: Consumer Health News Source Type: news

Potential preventative treatment demonstrated for Crohn's disease
(University of Alabama at Birmingham) A potential preventive treatment for Crohn's disease, a form of inflammatory bowel disease, has been demonstrated in a mouse model and using immune-reactive T cells from patients with Crohn's disease. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - December 21, 2020 Category: Biology Source Type: news

Can Marijuana or CBD Help With Ulcerative Colitis?
Can marijuana or CBD help manage the symptoms of ulcerative colitis? (Source: WebMD Health)
Source: WebMD Health - December 18, 2020 Category: Consumer Health News Source Type: news

Can Marijuana or CBD Help With My Crohn's Disease?
There’s a little evidence that cannabis may help with some symptoms of Crohn’s, including improving appetite and sleep, but there's a lot to consider first before you try it. Learn more. (Source: WebMD Health)
Source: WebMD Health - December 18, 2020 Category: Consumer Health News Source Type: news

How Alcohol Affects Crohn's Disease and the Medicines You Take to Treat It
Is it safe to have a drink if you have Crohn's disease? Learn how alcohol affects Crohn's disease and the medicines you take to treat it. (Source: WebMD Health)
Source: WebMD Health - December 18, 2020 Category: Consumer Health News Source Type: news

Join us virtually: 2021 Crohn's & Colitis Congress ®
(American Gastroenterological Association) Media are invited to register for the first virtual Crohn's& Colitis Congress, taking place Jan. 21-24, 2021, and learn about the latest trends and research in inflammatory bowel disease (IBD) patient care. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 18, 2020 Category: International Medicine & Public Health Source Type: news

Socioeconomic Status Tied to Inflammatory Bowel Disease Outcomes
THURSDAY, Dec. 17, 2020 -- Lower socioeconomic status (LSS) is associated with worse outcomes for inflammatory bowel disease (IBD), according to a study published in the December issue of The American Journal of Gastroenterology. Charles N.... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - December 17, 2020 Category: Pharmaceuticals Source Type: news

UC: How Can It Affect Your Sex Life?
If you have ulcerative colitis, you might be wondering whether it’s possible to have a satisfying sex life. The short answer is yes. (Source: WebMD Health)
Source: WebMD Health - December 16, 2020 Category: Consumer Health News Source Type: news

Gilead downsizes multibillion-dollar deal once at center of CEO's rebuild
Gilead and partner Galapagos no longer will pursue clinical trials in the United States with filgotinib in rheumatoid arthritis and other conditions, but still could pursue the drug as a treatment for inflammatory bowel disease. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - December 15, 2020 Category: Biotechnology Authors: Ron Leuty Source Type: news

Gilead downsizes multibillion-dollar deal once at center of CEO's rebuild
Gilead and partner Galapagos no longer will pursue clinical trials in the United States with filgotinib in rheumatoid arthritis and other conditions, but still could pursue the drug as a treatment for inflammatory bowel disease. (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - December 15, 2020 Category: American Health Authors: Ron Leuty Source Type: news

New Clues to Crohn's Disease in Kids
Title: New Clues to Crohn's Disease in KidsCategory: Health NewsCreated: 12/14/2020 12:00:00 AMLast Editorial Review: 12/15/2020 12:00:00 AM (Source: MedicineNet Digestion General)
Source: MedicineNet Digestion General - December 15, 2020 Category: Nutrition Source Type: news

New Clues to Crohn's Disease in Kids
MONDAY, Dec. 14, 2020 -- Important clues about Crohn's disease in children have emerged in new research. Scientists analyzed gene expression in individual cells in the inner lining (epithelium) of the intestines of human fetuses, six to 10 weeks... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - December 14, 2020 Category: General Medicine Source Type: news

Does Histologic Remission Offer Benefit for UC Patients? Does Histologic Remission Offer Benefit for UC Patients?
Do ulcerative colitis patients in endoscopic remission obtain additional benefit from achieving histologic remission?Alimentary Pharmacology & Therapeutics (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - December 14, 2020 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Ustekinumab for Ulcerative Colitis Through 2 Years of Therapy Ustekinumab for Ulcerative Colitis Through 2 Years of Therapy
This long-term extension study assessed the efficacy and safety of one additional year of ustekinumab maintenance treatment in patients originally manifesting moderate-to-severe ulcerative colitis.Alimentary Pharmacology & Therapeutics (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - December 9, 2020 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

UBCO researchers suggest stool transplants can battle serious infections
(University of British Columbia Okanagan campus) Could number two be number one when it comes to combating recurrent Clostridium difficile (CDI) infections? Using genetic material analysis and machine learning, UBC researchers have pinpointed several key factors to ensure successful fecal microbiota transplants (FMT), which have proven successful in treating bacterial infections in the gut including illnesses like C. difficile, Crohn's Disease, Colitis and even obesity, explains lead author Negin Kazemian. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 9, 2020 Category: International Medicine & Public Health Source Type: news

Consumer Health: Treating Crohn's disease and ulcerative colitis
Inflammatory bowel disease, or IBD, is an umbrella term used to describe disorders that involve chronic inflammation of your digestive tract. IBD can be debilitating and sometimes leads to life-threatening complications. Crohn's disease and ulcerative colitis are two types of IBD. Crohn's disease is characterized by inflammation of the lining of your digestive tract, which often [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - December 9, 2020 Category: Databases & Libraries Source Type: news

FDA approves Xolair ® (omalizumab) for adults with nasal polyps
             Basel, 01 December 2020 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the U.S. Food and Drug Administration (FDA) has approved the company ’s supplemental Biologics License Application (sBLA) for Xolair® (omalizumab) for the add-on maintenance treatment of nasal polyps in adult patients 18 years of age and older with inadequate response to nasal corticosteroids.1 Nasal polyps can lead to a loss of smell and nasal congestion, and frequently co-occur with other respiratory conditions, such as allergies and asthma. With this ap...
Source: Roche Media News - December 1, 2020 Category: Pharmaceuticals Source Type: news

FDA approves Xolair ® (omalizumab) for adults with nasal polyps
             Basel, 01 December 2020 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the U.S. Food and Drug Administration (FDA) has approved the company ’s supplemental Biologics License Application (sBLA) for Xolair® (omalizumab) for the add-on maintenance treatment of nasal polyps in adult patients 18 years of age and older with inadequate response to nasal corticosteroids.1 Nasal polyps can lead to a loss of smell and nasal congestion, and frequently co-occur with other respiratory conditions, such as allergies and asthma. With this ap...
Source: Roche Investor Update - December 1, 2020 Category: Pharmaceuticals Source Type: news

Vitamin D regulates calcium in intestine differently than previously thought
(Rutgers University) A Rutgers study has discovered that vitamin D regulates calcium in a section of the intestine that previously was thought not to have played a key role. The findings have important implications on how bowel disease, including ulcerative colitis and Crohn's disease, may disrupt calcium regulation. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 1, 2020 Category: International Medicine & Public Health Source Type: news

$11M NIH grant will fund biomedical research at University of Delaware
(University of Delaware) The National Institutes of Health has renewed a Center of Biomedical Research Excellence (COBRE) grant, worth more than $11 million. The University of Delaware Center is focused on discovery of new molecules that can be used to study and treat diseases such as breast cancer, renal cancer, Crohn's disease, tuberculosis and Legionnaires disease. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - November 30, 2020 Category: Biology Source Type: news

Breakthroughs in Crohn's Disease From ACG 2020 Virtual Breakthroughs in Crohn's Disease From ACG 2020 Virtual
Key studies on Crohn's disease from the ACG 2020 virtual meeting include the longer-term efficacy of drug therapy, the impact of combination treatment, and factors affecting surgical outcomes.Medscape (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 18, 2020 Category: Consumer Health News Tags: None ReCAP Source Type: news

Key Studies in Ulcerative Colitis From ACG 2020 Virtual Key Studies in Ulcerative Colitis From ACG 2020 Virtual
Highlights in ulcerative colitis from the ACG 2020 virtual meeting include the OCTAVE tofacitinib trial program, the long-term and comparative efficacy of vedolizumab, and long-term colectomy trends.Medscape (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 18, 2020 Category: Consumer Health News Tags: None ReCAP Source Type: news

Genetics Tied to Thromboembolism Risk With Inflammatory Bowel Disease
WEDNESDAY, Nov. 18, 2020 -- Genetic variants in some patients with inflammatory bowel disease (IBD) are associated with a significantly increased risk for developing thromboembolic disease (TED), according to a study published online Oct. 21 in... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 18, 2020 Category: Pharmaceuticals Source Type: news

MRE Predicts Response to TNF-a Inhibitors in Crohn's Disease MRE Predicts Response to TNF-a Inhibitors in Crohn's Disease
This study evaluated the use of magnetic resonance enterography to identify predictors of long-term healing of severe inflammation under treatment with TNF-alpha inhibitors.Alimentary Pharmacology & Therapeutics (Source: Medscape Radiology Headlines)
Source: Medscape Radiology Headlines - November 18, 2020 Category: Radiology Tags: Gastroenterology Journal Article Source Type: news

Kurogane holly contains anti-cancer compounds for IBS patients
(Natural News) Colitis-associated cancer (CAC) is one of the most serious complications of inflammatory bowel disease (IBD), an umbrella term for disorders that cause chronic inflammation of the digestive tract. An important risk factor for colon cancer, IBDs – either ulcerative colitis or Crohn s disease – often precede CAC, which is a type of inflammation-driven... (Source: NaturalNews.com)
Source: NaturalNews.com - November 17, 2020 Category: Consumer Health News Source Type: news

Tool Predicted Vedolizumab Nonresponse in Routine Practice Tool Predicted Vedolizumab Nonresponse in Routine Practice
Among patients with ulcerative colitis who were treated in routine practice, a point-based clinical scoring tool predicted nonresponse to vedolizumab therapy.Medscape Medical News (Source: Medscape Internal Medicine Headlines)
Source: Medscape Internal Medicine Headlines - November 13, 2020 Category: Internal Medicine Tags: Gastroenterology News Source Type: news

Life Expectancy Gap Persists for IBD Patients Life Expectancy Gap Persists for IBD Patients
Life expectancy increased for adults with inflammatory bowel disease (IBD) over recent decades, but still remained lower than life expectancy for individuals without IBD.Medscape Medical News (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - November 13, 2020 Category: Gastroenterology Tags: Gastroenterology News Source Type: news

Optimum Number of Biopsies to Assess Inflammation in UC Optimum Number of Biopsies to Assess Inflammation in UC
What are the minimum number of biopsies required to adequately assess histological disease activity in ulcerative colitis patients?Alimentary Pharmacology & Therapeutics (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 11, 2020 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Cytocom, Inc. Appoints Taunia Markvicka, PharmD., MBA, Chief Operating Officer
Industry veteran to lead corporate strategy and prepare for commercialization of Cytocom's immune-modulating therapies developed with AIMS technology platform WINTER PARK, Fla., Nov. 10, 2020 -- (Healthcare Sales & Marketing Network) -- Cytocom, Inc. (... Biopharmaceuticals, Personnel Cytocom, immunotherapy, Crohn's disease, fibromyalgia, pancreatic cancer (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 10, 2020 Category: Pharmaceuticals Source Type: news

Aviara Pharmaceuticals, Inc receives grant to collaborate with the Texas Heart Institute
(Texas Heart Institute) Aviara Pharmaceuticals, Inc. to collaborate with the Texas Heart Institute (THI) to develop a small molecule drug that targets inflammatory cell trafficking to the gut as a safe alternative to current treatment strategies in inflammatory bowel disease (IBD) under a Phase I Small Business Technology Transfer (STTR) award by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a division of the National Institutes of Health (NIH). (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 10, 2020 Category: International Medicine & Public Health Source Type: news

Life Expectancy Has Increased for Individuals With IBD
MONDAY, Nov. 9, 2020 -- Life expectancy has increased for individuals with inflammatory bowel disease (IBD), but there is still a gap in life expectancy for those with and without IBD, according to a study published online Nov. 9 in CMAJ, the... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 9, 2020 Category: Pharmaceuticals Source Type: news

Can Having IBD Shorten Your Life?
MONDAY, Nov. 9, 2020 -- People with inflammatory bowel disease (IBD) live longer than they used to, but still die at a younger age than those without the condition, a new study out of Canada finds. IBD includes Crohn's disease and ulcerative... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - November 9, 2020 Category: General Medicine Source Type: news

Prometheus Biosciences Announces $130 Million Financing to Advance Precision Medicines for the Treatment of Inflammatory Bowel Disease
New investors include Eventide, RTW, Perceptive Advisors, Cormorant Capital, Cowen Healthcare Investments and Point72 Proceeds to accelerate clinical development of PRA023, a potential best in class TL1A antibody for IBD, and expansion of Promtheus' 360... Biopharmaceuticals, Venture Capital, Personnel Prometheus Biosciences, precision medicine, inflammatory bowel disease (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 9, 2020 Category: Pharmaceuticals Source Type: news

People with inflammatory bowel disease still die earlier despite increase in life
(Canadian Medical Association Journal) A study comparing life expectancy of people with inflammatory bowel disease (IBD) and without found that, while life expectancy increased for both groups, people with IBD generally died sooner. The study is published in CMAJ (Canadian Medical Association Journal) http://www.cmaj.ca/lookup/doi/10.1503/cmaj.190976. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - November 9, 2020 Category: International Medicine & Public Health Source Type: news

COVID-19: Enzyme targeted by virus also influences gut inflammation
(Cedars-Sinai Medical Center) An enzyme that helps COVID-19 (coronavirus) infect the body also plays a role in inflammation and patient outcomes in inflammatory bowel disease (IBD), according to a new study led by Cedars-Sinai. The findings raise the possibility that anti-inflammatory drug therapies for IBD may aid recovery from coronavirus. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 5, 2020 Category: International Medicine & Public Health Source Type: news

ACG: Resilience-Based Care Coordination Program Benefits IBD
MONDAY, Nov. 2, 2020 -- The Gaining Resilience Through Transitions (GRITT) methodology, a resilience-based care coordination approach to chronic disease, can reduce health care utilization in patients with inflammatory bowel disease (IBD), according... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 2, 2020 Category: Pharmaceuticals Source Type: news

Athos Therapeutics Announces Appointment of Chief Business Officer
LOS ANGELES, Nov. 2, 2020 -- (Healthcare Sales & Marketing Network) -- Athos Therapeutics Inc., a late pre-clinical stage biotechnology company pioneering the development of first-in-class precision therapeutics for patients with autoimmune diseases and c... Biopharmaceuticals, Personnel Athos Therapeutics, Ulcerative Colitis, Crohn's Disease (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 2, 2020 Category: Pharmaceuticals Source Type: news

Microbiota May Reflect Disease Activity, Outcome in IBD Microbiota May Reflect Disease Activity, Outcome in IBD
This comprehensive review explores the feasibility of gut microbiome composition as a monitor of disease activity and predictor of response to therapy in inflammatory bowel disease.Alimentary Pharmacology & Therapeutics (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 2, 2020 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news